These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16861877)

  • 1. [The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication].
    Lee JH; Hong SP; Kwon CI; Phyun LH; Lee BS; Song HU; Ko KH; Hwang SG; Park PW; Rim KS; Kim S
    Korean J Gastroenterol; 2006 Jul; 48(1):19-24. PubMed ID: 16861877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication].
    Kang MS; Park DI; Yun JW; Oh SY; Yoo TW; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2006 Jan; 47(1):30-6. PubMed ID: 16434866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication].
    Jung HS; Shim KN; Baik SJ; Na YJ; Kang MJ; Jung JM; Ha CY; Jung SA; Yoo K
    Korean J Gastroenterol; 2008 May; 51(5):285-90. PubMed ID: 18516012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
    Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
    Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
    Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
    Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.
    Chuah SK; Tai WC; Hsu PI; Wu DC; Wu KL; Kuo CM; Chiu YC; Hu ML; Chou YP; Kuo YH; Liang CM; Chiu KW; Hu TH
    Helicobacter; 2012 Oct; 17(5):374-81. PubMed ID: 22967121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J; Alvarez B; Mendez L; Cruz ME
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
    Schrauwen RW; Janssen MJ; de Boer WA
    Neth J Med; 2009 Mar; 67(3):96-101. PubMed ID: 19307680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
    Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
    J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
    Kuo CH; Hu HM; Kuo FC; Hsu PI; Chen A; Yu FJ; Tsai PY; Wu IC; Wang SW; Li CJ; Weng BC; Chang LL; Jan CM; Wang WM; Wu DC
    J Antimicrob Chemother; 2009 May; 63(5):1017-24. PubMed ID: 19246508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
    Wong WM; Gu Q; Lam SK; Fung FM; Lai KC; Hu WH; Yee YK; Chan CK; Xia HH; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2003 Feb; 17(4):553-60. PubMed ID: 12622764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
    Hu TH; Chuah SK; Hsu PI; Wu DC; Tai WC; Chiu YC; Wu KL; Kuo CM; Hu ML
    Am J Med Sci; 2011 Sep; 342(3):177-81. PubMed ID: 21804375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
    Calhan T; Kahraman R; Sahin A; Senates E; Doganay HL; Kanat E; Ozdil K; Sokmen HM
    Helicobacter; 2013 Oct; 18(5):378-83. PubMed ID: 23601026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication.
    Ozdil K; Calhan T; Sahin A; Senates E; Kahraman R; Yüzbasioglu B; Demirdag H; Demirsoy H; Sökmen MH
    Hepatogastroenterology; 2011; 58(109):1148-52. PubMed ID: 21937367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
    Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A
    Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
    Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC;
    Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.